The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing – CNBC
Business News
- The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing CNBC
- Venture Investment in Crispr Gene Editing Spurs Innovation, Hunt for IP The Wall Street Journal
Source: Business News